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1. Introduction
  Urinary Tract Infection’s (UTI’s) pose a serious health 
threat with respect to antibiotic resistance and high 
recurrence rates[1]. Escherichia coli（E. coli）are one of the 
most prevalent pathogens among gram-negative bacteria, 
capable of causing complicated and uncomplicated 
UTI’s[2,3]. According to Foxman[4], uropathogenic E. coli 
(UPEC) are the primary cause of community-acquired 
urinary tract infections (UTI) (70%-95%) and a large portion 
of nosocomial UTI’s (50%).  Mulvey et al[5] and Bower et 
al[6]   have reported that, UPEC strains act as a opportunistic 
intracellular pathogens which colonizes the bladder of 
the urinary tract, causing cystitis and also ascend through 
the ureters into the kidneys, causing pyelonephritis. 
Uropathogenic E. coli forms intracellular bacterial 
communities with many biofilm like properties within the 
bladder epithelium[7]. 
  Biofilms have a role in up to 60% of human infections and 
they are difficult to eradicate with antimicrobial treatment. 
In vitro susceptibility tests have shown considerable 
increase in resistance of biofilm cells to killing[8]. Biofilms 
can be regarded as a universal strategy for bacterial survival 
which positions them to effectively use the available 
nutrients. They largely consist of polysaccharides, which 
prevents the access of antibacterial agents, antibodies and 
white blood cells. Planktonic cells are highly susceptible 
to antibiotics than the sessile bacterial cells in the biofilms 
which can withstand the host immune responses[9]. So the 
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concentrations of antibiotics needed to kill bacteria in the 
sessile phase are often much higher than those required for 
bacteria in the planktonic phase[10]. Resistance can be due 
to production of inactivating enzymes and there is evidence 
that the relatively large amounts of antibiotic inactivating 
enzymes such as beta-lactamases which accumulate within 
the glycocalyx produce concentration gradients can protect 
underlying cells[11]. 
  The in vitro detection of biofilms of uropathogenic E. coli 
and antimicrobial susceptibility pattern among UTI patients 
has been documented across the globe. This study would 
serve as a useful guidance for the health care providers 
especially the physicians’ choice of antibiotics for the 
treatment of biofilm infections among UTI patients. 
2. Materials and methods
  A total of 100 consecutive non-repetitive E. coli strains 
were isolated from 166 urine specimens of UTI patients 
attending tertiary care hospitals in and around Coimbatore, 
South India over a period of 1 year and they were subjected 
for biofilm production. Identification of the strain was 
based on cultural characteristics and reactions in standard 
biochemical tests[12]. All E. coli strains were included in the 
study and were analyzed for the production of biofilm and 
antimicrobial susceptibility pattern. 
2.1. Detection of biofilm formation and antibiotic 
susceptibility pattern
  All the 100 E. coli strains were subjected to biofilm 
production and the numbers of tests are available to 
identify biofilm producing E. coli by methods including 
Tissue Culture Plate method[13], Tube method[14] and Congo 
Red Agar method[15]. The above strains were tested for 
antimicrobial susceptibility by disc diffusion technique 
according to Clinical and Laboratory Standards Institute 
guidelines[16] with commercially available discs (Hi-Media, 
Mumbai). The following antibiotic discs (drug concentration 
in 毺g) were used: ampicillin (10), amikacin (30), 
amoxicillin / clavulanic acid (20/10, 30), co-trimoxazole 
(25), ceftazidime (30), cephotaxime (30), chloramphenicol 
(30), gentamicin (30), imipenem (10), norfloxacin (10), 
piperacillin/tazobactam (100/10), tobramycin (10) and 
tetracycline (30).
3. Results
  Of the 166 urine specimens of urinary tract infection 
processed, 146 (87.9%) specimens showed culture positive 
and the rest 20 (12.0%) were negative. Among the strains, 
aerobic gram negative E. coli was 100 (68.5%) and other 
organisms were 46 (31.5%). Among 100 E. coli strains 
subjected to biofilm production, 17(17%) strains showed 
highly positive, 19 strains (19%) showed moderate positive, 
36 strains (36%) showed weakly positive in tube method. 
Similarly, in Congo Red Agar method (CRA), 23 strains (23%) 
showed highly positive, 37 strains (37%) showed moderate 
positive and 40 strains (40%) were weakly positive, whereas 
in Tissue Culture Plate Method (TCP), 6(6%) strains showed 
highly positive, 80 strains (80%) showed moderate positive 
and 14 strains (14%) showed weakly positive.
3.1. Correlation of biofilm producing strains with multiple 
drug resistance strains
  When analyzed among  the strains exhibiting resistance 
to various commonly used antibiotics with the strains 
producing biofilm, it was found that the resistance pattern of 
the strains producing strong positive (17+++), weakly positive 
(19++) and moderate positive (36+) were found to be 88.2%, 
84.2% and 38.8 % respectively. There was also a significant 
correlation between biofilm production and resistance to 
multiple antibiotics such as ampicillin, amikacin, co-
Table 1 
Antibiotic susceptibility result of the biofilm producing uropathogenic E. coli (%).
Antibiotics
Biofilm    producer Non-biofilm producer
Resistance Sensitive Resistance Sensitive
Amikacin   70   30 66   34
Amoxyclav 100 - 88   12
Ampicillin   64   36 50   50
Co-trimoxazole   83   17 53   47
Ceftazidime   84   16 70   30
Cephotaxime   86   14 74   26
Chloramphenicol 100 -   3   97
Gentamicin   86   14 83   17
Imipenem - 100 - 100
Norfloxacin   59   41 33   67
Piperacillin/Tazobactam   83   17 76   24
Tobramycin   66   34 55   45
Tetracycline   75   25 50   50
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trimoxazole, norfloxacin and these strains were found to 
show increased biofilm production. In this study, resistance 
of 70.6% against ampicillin, amikacin and co-trimoxazole, 
58.8% against ampicillin, amikacin and norfloxacin, 
47.1% against ampicillin, amikacin, co-trimoxazole, 
norfloxacin, 41.2% against gentamicin and tetracycline 
and 35.3% against ampicillin, amikacin, co-trimoxazole, 
norfloxacin and piperacillin/tazobactam were observed. 
Thus the different combination of antibiotics resulted in 
varying degree of resistance among the biofilm producing 
uropathogenic E. coli.
3.2. Antibiotic susceptibility result of the biofilm producing 
uropathogenic E. coli
  The multi-drug resistant pattern of the biofilm producing 
E. coli is shown in Table 1. All the biofilm forming strains 
showed maximum resistance to amoxyclav (100%), followed 
by chloramphenicol (100%), gentamicin and cephotaxime 
(86%), ceftazidime (84%), co-trimoxazole (83%), and 
amikacin (70%). Both biofilm producer and non- biofilm 
producer were highly resistant to amoxyclv, followed 
by gentamicin and piperacillin/tazobactam. However, 
resistance to other four antibiotics such as co-trimoxazole 
(83% vs. 53%), tetracycline (75% vs. 50%) and ampicillin 
(64% vs. 50%) was comparatively higher among biofilm 
producer than non-biofilm producer. Resistance among 
biofilm producer to norfloxacin was also higher (59% vs. 
33%), when compared with non-biofilm producers. 100% 
sensitive was noticed for both biofilm and non-biofilm 
producer only against imipenem.
4. Discussion
  In the community, bacterial infection of the urinary tract is 
one of the common causes for an individual to seek medical 
attention[17]. The pathogens causing UTI’s are almost always 
predictable, with E. coli being the primary etiological agent 
among the patients[18,19]. Easier methods for diagnosing 
and quantifying biofilm associated infection and ideal 
device surface would surely help in the fight against biofilm 
formation[20]. In the current study, 6% of strains were in 
vitro positive for biofilm production by TCP method. This 
is relatively lower than biofilm forming capabilities of 
uropathogenic E. coli reported in other studies[21].
  Bacterial biofilm are often associated with long-term 
persistence of organism in various environments. Bacteria 
in biofilm display dramatically increased resistance to 
antibiotics[22]. The findings of the current investigations 
are in agreement with the reports of Reisner et al[23]; Ong 
et al[24]; Ulett et al[25] and Ulett et al[26] in which a greater 
variation was observed against the uropathogenic E. coli 
forming biofilms under different conditions. Another finding 
of this study is that strong biofilm producers were less 
susceptible to antimicrobial agents than the non-biofilm 
producer. This result may agree with the previous studies 
showing that the sessile bacterial cells seems to exhibit 
higher resistance than the planktonic cells[27-33], so the 
findings of the current investigation indicated that resistance 
mechanisms are associated with the formation of biofilm 
among uropathogenic E. coli.
  Understanding the nature of intracellular bacterial 
communities in recurrent urinary tract infections will help 
in the development of new and more effective antimicrobial 
agents for treating infections due to biofilms[34]. It is 
commonly accepted that biofilms are more resistant to 
antibiotics than planktonic cells. Even in the present 
study, UPEC biofilm were highly resistant to antibiotics. 
The beta-lactam antibiotics cephotaxime and ceftazidime, 
and the aminoglycosides gentamicin and amikacin were 
hardly effective. There are several reasons why these 
antibacterial agents are not as effective on biofilm cells 
as they are on planktonic cells. Some antibiotics, such as 
beta-lactams, require rapid bacterial growth to kill cells[7]. 
The biofilm producing E. coli strains were resistant to at 
least 6 antimicrobial agents which calls for an urgent need 
to regulate the overuse of antibiotics. This would limit the 
spread of resistant microorganisms in the community as well 
as in hospital settings.
  Biofilm formation is closely related with the resistance 
of E. coli towards the antimicrobial drugs and also it 
increases the chronicity of urinary tract infection. There is 
an association between biofilm production and antibiotic 
resistance. Therefore, the UTI caused by biofilm producing 
E. coli, may promote the colonization and increased the 
incidence rate of UTI’s. 
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